Degradable carbon nanotube-containing biosensors and methods for target clinical marker detection
US10881332B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2017 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Aug 17, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/92
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to carbon nanotube-containing composites as biosensors to detect the presence of target clinical markers, methods of their preparation and uses in the medical field. The invention is particularly suitable for the detection in patient biological specimens of bone markers and tissue markers. The biosensors of the invention include carbon nanotubes deposited on a substrate, gold nanoparticles deposited on the carbon nanotubes and, binder material and biomolecule deposited on the gold-coated carbon nanotubes. The biomolecule is selected to interact with the target clinical markers. The biosensor can be used as an in-situ or an ex-situ device to detect and measure the presence of the target clinical markers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.